Assessing the role of measuring plasma neurofilament light levels in ALS

(1:58)

Plasma neurofilament light as a biomarker of neurodegeneration and memory function in older adults

(47:58)

Diagnostic value of plasma neurofilament light: A multicentre validation study

(3:18)

Prognostic accuracy of plasma NfL to predict Alzheimer’s disease dementia

(4:22)

Using plasma biomarkers in the diagnosis of Alzheimer’s disease

(1:36)

Plasma NfL as a biomarker for frontotemporal dementia

(1:21)

Serum NfL: a first-in-class biomarker paving the way towards precision medicine in MS

(2:29)

Predicting conversion to Alzheimer’s disease with plasma NfL

(1:33)

Neurofilament light chain: Bjorn Oskarsson, M.D.

(15:10)

DROP-AD: detecting Alzheimer’s disease biomarkers in a single blood spot

(5:25)

Plasma Concentration of the Neurofilament Light Protein (NFL) is a Biomarker of CNS I... | RTCL.TV

(1:17)

Promising FONLISA test for ultrasensitive detection of plasma NfL in Alzheimer’s disease

(3:58)

Plasma Concentration of the Neurofilament Light Protein (NFL) is a Biomarker of CNS I... | RTCL.TV

(1:14)

The Rotterdam study: associations between plasma NfL and neurodegenerative disease

(2:17)

Alzheimer’s disease plasma biomarkers across the spectrum: which perform best?

(2:9)

The potential of NfL as a biomarker in neurodegenerative diseases

(2:2)

Blood biomarkers of disease activity in MS

(3:32)

Plasma Concentration of the Neurofilament Light Protein (NFL) is a Biomarker of CNS I... | RTCL.TV

(1:25)